Menu
Recruiting NCT07025421

The ARISE Study - Use of Vertical Positioning

No phase Interventional Acute Respiratory Distress Syndrome

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Intervention Upright Bed positioning.
Who it may be relevant to
Registry conditions: Acute Respiratory Distress Syndrome. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The Arise Study - Use of Vertical Positioning

Overview

The pilot study will randomize 40 ARDS patients who if proning were required would be randomized to upright bed positioning or to stand of care with bed in the head of bed elevation position

Detailed description

Patients will be randomized to receive either daily upright bed positioning or to receive standard of care with head of bed elevated.

Interventions

  • Other Intervention Upright Bed positioning
    Patient in receipt of the upright bed positioning will receive daily upright bed positioning time each day of mechanical ventilation following the time required by institutional protocol for ARDS - associated prone positioning

Primary outcome measures

  • Change in Tidal Volume [Time frame: within first 7 days of mechanical ventilation]

Eligibility criteria

Inclusion criteria

\- Acute Respiratory Distress Syndrome

Exclusion criteria

  • Cancer
  • Active tracheostomy

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • University of Alabama at Birmingham — Birmingham

Identifiers

NCT: NCT07025421 · IRB-300014712 · UAB

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗